“Prolonged Response to Recombinant Human Erythropoietin Treatment in Patients With Myelodysplastic Syndrome at a Single Referral Centre in Brazil”. Clinics, vol. 74, May 2019, p. e771, https://doi.org/10.6061/clinics/2019/e771.